Olink reports second quarter 2023 financial results
August 09, 2023 07:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the second quarter ended June 30, 2023. ...
Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platform
August 08, 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) has...
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
July 13, 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2023 before the market...
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
July 13, 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2023 before the market...
Announcing Olink® Explore HT – A New Era in Proteomics
July 12, 2023 09:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, July 12, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink® Explore HT, a transformational solution for high-throughput...
Revealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studies
June 28, 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, June 28, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of new findings into the variability of the human proteome, based on...
Revealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studies
June 28, 2023 08:00 ET
|
Olink Proteomics AB
Uppsala, Sweden, June 28, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of new findings into the variability of the human proteome, based on...
Olink to participate in June investor events
May 25, 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, May 25, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events: William...
Olink reports first quarter 2023 financial results
May 11, 2023 07:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, May 11, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the first quarter ended March 31, 2023. ...
Report from the Annual General Meeting of Olink Holding AB (publ) on 17 April 2023
April 17, 2023 16:05 ET
|
Olink Proteomics AB
UPPSALA, Sweden, April 17, 2023 (GLOBE NEWSWIRE) -- At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 17 April 2023 the AGM adopted,...